✦ LIBER ✦

Findings from a randomized, placebo-control, clinical trial examining the potential cognitive effects of soy isoflavones in patients with Alzheimer's disease

✍ Scribed by Gleason, Carey; Dowling, N. Maritza; Setchell, Kenneth; Carlsson, Cynthia; Barnet, Jodi; Johnson, Sterling; Atwood, Craig; Asthana, Sanjay

Book ID: 122043880
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 185 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.09.112

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of donepezil in pati

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

✍ Howard Feldman; Serge Gauthier; Jane Hecker; Bruno Vellas; Yikang Xu; John R. Ie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

## Abstract ## Background There have been very limited investigations of cholinesterase inhibitor therapy in more advanced stages of Alzheimer's disease (AD). The efficacy and safety of donepezil were evaluated in __post hoc__ analyses of a subgroup of patients with more severe AD (standardized Mi

Effects of memantine on global clinical

Effects of memantine on global clinical status in patients with moderate Alzheimer's: Results of a 12-week, randomized, placebo-controlled trial

✍ Stephen M. Graham; Robert K. Hofbauer; Suzanne Hendrix; Michael Tocco; James L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Effects of non-steroidal anti-inflammato

Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial

✍ Jeannie-Marie S. Leoutsakos; Bengt O. Muthen; John C.S. Breitner; Constantine G. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

Saffron in the treatment of patients wit

Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial

✍ S. Akhondzadeh; M. Shafiee Sabet; M. H. Harirchian; M. Togha; H. Cheraghmakani; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

P1-387 Results of a randomized, double-b

P1-387 Results of a randomized, double-blind, placebo-controlled trial with the neurotrophic compound cerebroylsin in Alzheimer's disease patients

✍ Antón Álvarez; Marta Laredo; Carolina Sampedro; Ramón Cacabelos; Verónica Coucei 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Effects of sulfasalazine on 6-mercaptopu

Effects of sulfasalazine on 6-mercaptopurine metabolism and clinical efficacy in patients with Crohn’s disease: preliminary results of a placebo-controlled randomized clinical trial

✍ Jean-Paul Achkar; Aaron Brzezinski; Douglas Seidner; Deborah Vogel; Bo Shen; Bre 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB